Van Well Daan 4
4 · SOPHiA GENETICS SA · Filed Apr 10, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CLO Daan Van Well Sells Shares
What Happened
Daan Van Well, Chief Legal Officer of SOPHiA GENETICS (SOPH), sold a total of 4,849 shares in two open‑market transactions to satisfy tax withholding on recently vested restricted stock units. On 2026‑04‑08 he sold 2,861 shares at a weighted average price of $4.85 for proceeds reported as $13,862. On 2026‑04‑09 he sold 1,988 shares at a weighted average price of $4.74 for proceeds reported as $9,424. These were sales (not purchases).
Key Details
- Transaction dates: 2026‑04‑08 (2,861 shs @ $4.85, reported $13,862) and 2026‑04‑09 (1,988 shs @ $4.74, reported $9,424). Total sold: 4,849 shares for ~$23,286.
- Price ranges: 4/8 sale prices ranged $4.78–$4.94 (weighted avg $4.85); 4/9 sale prices ranged $4.61–$4.86 (weighted avg $4.74). Reporting person will provide breakdown by price on request.
- Purpose and plan: Sales were made to satisfy tax withholding on RSU vesting (April 2 and 3, 2026) and were effected under a pre‑established Rule 10b5‑1 trading plan — non‑discretionary routine transactions.
- Filing timeliness: Form 4 filed 2026‑04‑10 for transactions on 4/8 and 4/9 — appears to be timely (not marked late).
- Post‑transaction holdings: Not specified in the provided excerpt of the filing.
Context
These sales were tax‑withholding transactions tied to RSU vesting and executed under a 10b5‑1 plan, which is common and generally considered routine rather than a directional signal about the company. Retail investors may view routine tax‑related sales differently than discretionary insider selling; purchases by insiders tend to be more informative about confidence in the stock.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-04-08$4.85/sh−2,861$13,862→ 350,808 total - Sale
Ordinary Shares
[F1][F3]2026-04-09$4.74/sh−1,988$9,424→ 348,820 total
Footnotes (3)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.78 to $4.94, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.86, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.